Výsledky vyhledávání - "G M Galstyan"

Akademický článek

The use of low doses of gabapentin in patients with neuropathic pain and with thrombocytopenia

Autor: O. K. Levchenko, E. G. Gemdzhian, G. M. Galstyan

Publikováno v: Вестник анестезиологии и реаниматологии, Vol 21, Iss 3, Pp 42-46 (2024)

Introduction. Approximately 21–27% of patients with blood system diseases receive opioid analgesics, with neuropathic pain being one of the most common reasons for prescription. Gabapentin is used as a first-line drug for neuropathic pain (NP), but

Externí odkaz: https://doaj.org/article/f448282563b34d179009da09d00e8541

Zobrazit plný text záznamu

Akademický článek

Diagnosis of thrombotic thrombocytopenic purpura

Autor: G. M. Galstyan, E. E. Klebanova

Publikováno v: Терапевтический архив, Vol 92, Iss 12, Pp 207-217 (2020)

Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disease, disease, characterised by microangiopathic hemolytic anaemia, consumption thrombocytopenia, and organ dysfunction. The pathogenesis of TTP is attributed to the deficiency

Externí odkaz: https://doaj.org/article/cee146f1863e4301bf6d387f607bc6ce

Zobrazit plný text záznamu

Akademický článek

Role of the intensive care in treatment of patients with acute myeloid leukemia

Autor: A V Bazhenov, G M Galstyan, E N Parovichnikova, V V Troitskaya, L A Kuzmina, Z T Fidarova, E O Gribanova, S A Makhinya, O A Latyshkevich, U A Chabaeva, S M Kulikov, V G Savchenko

Publikováno v: Терапевтический архив, Vol 91, Iss 7, Pp 14-24 (2019)

Aim. Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts). We evaluate influence of transfer to ICU and life threatening complication on early mortali

Externí odkaz: https://doaj.org/article/0f9fa6f9da044e4fb6fbb3950117b512

Zobrazit plný text záznamu

Akademický článek

POLYMORPHISM OF THROMBOPHILIA GENES AND THEIR ROLE IN DEVELOPMENT OF DIFFERENT DISEASE PHENOTYPES AND THROMBOTIC COMPLICATIONS IN HEMOPHILIA PATIENTS

Autor: T. Yu. Polyanskaya, I. S. Fevraleva, E. E. Karpov, N. V. Sadykova, M. S. Sampiev, A. V. Golobokov, G. V. Mishin, D. Yu. Petrovskiy, A. A. Koroleva, G. M. Galstyan, A. B. Sudarikov, V. Yu. Zorenko

Publikováno v: Сибирский научный медицинский журнал, Vol 39, Iss 1, Pp 106-111 (2019)

Objective was to study genetic markers of thrombophilia in patients with hemophilia, which can affect the course of the disease and contribute to thrombotic complications. Material and methods. The study included 96 patients with severe hemophilia: 7

Externí odkaz: https://doaj.org/article/a58242bb3c574a72918378882c15c458

Zobrazit plný text záznamu

Neurological disorders in patients with thrombotic thrombocytopenic purpura

Autor: G. M. Galstyan, E. E. Klebanova, S. Yu. Mamleeva, S. Yu. Fedorova, M. Yu. Drokov, G. A. Yatsyk

Publikováno v: Clinical Medicine (Russian Journal). 101:41-49

Aim: to analyze the first neurological manifestation in patient with thrombotic thrombocytopenic purpura (TTP). Material and methods. The appeals from physicians who suspected TTP were included in the study. The neurological symptoms in 40 patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ff7336ea38d9107e849ed1d7d037c85
https://doi.org/10.30629/0023-2149-2023-101-1-41-49

Zobrazit plný text záznamu

Comparison of the treatment results in adult patients with acute Ph-negative lymphoblastic leukemia on protocols of the Russian multicenter studies ALL-2009 and ALL-2016

Publikováno v: Russian journal of hematology and transfusiology. 67:460-477

Introduction. Over the past 5 years, signifi cant progress has been achieved in the treatment of patients with Ph-negative acute lymphoblastic leukemia (ALL). Treatment results were compared between two protocols of the Russian multicenter studies «

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::83008d7f13414967e0a7c982dd410338
https://doi.org/10.35754/0234-5730-2022-67-4-460-477

Zobrazit plný text záznamu

Akademický článek

Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow transplantation

Autor: G M Galstyan, M V Pashkova, O Y Popova, P M Makarova, D S Dubnyak, L A Kuzmina, E N Parovichnikova

Publikováno v: Терапевтический архив, Vol 90, Iss 1, Pp 60-64 (2018)

The case report of botulinum toxin treatment of gastroparesis in a patient following allogenic bone marrow transplantation is described. The causes of gastroparesis and methods of prevention and treatment are discussed. It was noted that pyloric inje

Externí odkaz: https://doaj.org/article/94bdf149d7b94c038cae1f02550c0123

Zobrazit plný text záznamu

Combination of ibrutinib and venetoclax followed by Chimeric Antigen Receptor T-cell therapy in the ﬁrst line of treatment in an elderly patient with mantle cell lymphoma with hyperleukocytosis and mutation in the TP53 gene

Autor: E. E. Zvonkov, D. A. Koroleva, N. G. Gabeeva, A. E. Shchekina, M. A. Telyashov, O. A. Aleshina, B. V. Biderman, A. B. Sudarikov, T. N. Obukhova, I. V. Galtseva, V. N. Dvirnik, V. V. Troitskaya, G. M. Galstyan, M. A. Maschan, E. N. Parovichnikova

Publikováno v: Russian journal of hematology and transfusiology. 67:441-452

Introduction. The tactics of therapy for elderly comorbid patients with mantle cell lymphoma with unfavorable prognosis factors (complex karyotype, 17p13 deletion, mutations in the TP53 gene) have not been developed. The use of intensive chemotherapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f76e06130fddea68f0e1c020d3e25725
https://doi.org/10.35754/0234-5730-2022-67-3-441-452

Zobrazit plný text záznamu

Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy

Publikováno v: Russian journal of hematology and transfusiology. 67:328-350

Introduction. Primary mediastinal lymphoma (PML) is an aggressive lymphoid tumor treatment success of which is determined by induction therapy. To date, none of the standard chemotherapy regimens (CT) have demonstrated an advantage in efﬁcacy. Inte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9e982c6740826df738fb2852f7b3049
https://doi.org/10.35754/0234-5730-2022-67-3-328-350

Zobrazit plný text záznamu

Intensive care of life-threatening complications in allogeneic hematopoietic stem cell recipients

Autor: A. E. Shchekina, G. M. Galstyan, M. Y. Drokov, L. A. Kuzmina, E. N. Denisova, N. M. Arapova, V. V. Troitskaya, E. N. Parovichnikova

Publikováno v: Russian journal of hematology and transfusiology. 67:308-327

Introduction. Life-threatening complications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) can have a signiﬁcant inﬂuence on the short-term and long-term prognosis in recipients of hematopoietic stem cells (allo-HSCs).Aim —

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8834d4d6d6b1a36eae937bde517b4b33
https://doi.org/10.35754/0234-5730-2022-67-3-308-327

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání